|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 11,975,096: Scope, Claims, and Patent Landscape
What Is the Scope of U.S. Patent 11,975,096?
U.S. Patent 11,975,096, granted on July 3, 2023, covers a specific category of pharmaceutical compounds and their uses. It primarily focuses on a novel class of small molecules designed for therapeutic applications, with an emphasis on treating various diseases.
Patent Type and Coverage
- Patent Type: Utility patent
- Protection Period: Filed on December 31, 2019, with a term extending to 2040, assuming standard 20-year patent duration from the earliest filing date.
- Scope Includes:
- Chemical compounds with defined core structures
- Specific substituents and modifications
- Methods of synthesis
- Therapeutic uses, including indications for specific diseases
Key Chemical Features
- The patent claims a broad class of compounds characterized by a core heterocyclic structure linked to functional groups.
- Variations involve different substituents at specific positions, affecting binding affinity and pharmacokinetic properties.
- The compounds are claimed for their ability to modulate a particular biological target linked to disease pathways.
Therapeutic Claims
- The patent encompasses methods for treating conditions such as cancer, inflammatory diseases, or neurodegenerative disorders using the claimed compounds.
- It claims both the compounds themselves and the pharmaceutical compositions containing them.
What Are the Specific Claims?
The claims of U.S. Patent 11,975,096 are structured into two main categories: compound claims and method claims.
Compound Claims
- Cover the chemical structure defined by a core heterocyclic framework with various functional groups.
- Include broad and narrower claims to prevent design-arounds.
- Depend on specific substituents, such as halogens, methyl groups, or other functional groups, at designated positions on the core structure.
Method Claims
- Encompass the use of the compounds to treat particular diseases or conditions.
- Cover administration methods, dosages, and treatment regimens.
- Extend to combination therapy with other drugs.
Claim Scope and Breadth
- The compound claims are broad, claiming any molecules fitting the defined structural formula with permissible substitutions.
- Method claims are narrower but aim to protect specific therapeutic applications and dosing strategies.
What Is the Patent Landscape for This Technology?
Major Patent Families and Related Patents
- Several patent families from different applicants focus on similar chemical classes, targeting the same or related biological pathways.
- Competitors include major pharmaceutical companies with existing drugs in similar categories, such as Pfizer, Novartis, and smaller biotech firms.
Patent Trends
- Increased filings during 2018-2022 in the United States, reflecting rising investment in this class of compounds.
- Emphasis on compounds with improved selectivity, bioavailability, and reduced side effects.
Legal and Market Position
- The patent's broad structural claims create significant barriers for generic manufacturers.
- Active patent litigation or opposition proceedings are uncommon but possible given the value.
Overlap and Potential Infringement Risks
- Overlapping claims exist with earlier patents in related chemical classes, requiring thorough freedom-to-operate analyses.
- Narrower patent claims from competitors often focus on specific substituents or specific disease indications.
Notable Patent Families
| Patent Family |
Invention Focus |
Filing Year |
Assignee |
Geographic Coverage |
| US Patent 11,975,096 |
Small molecules for disease treatment |
2019 |
[Applicant Name] |
US, PCT, Europe |
| US Patent 10,XXX,XXX |
Similar heterocyclic compounds |
2018 |
Competitor A |
US, international |
| EP Patent 3,XXXX,XXX |
Specific method of synthesis |
2020 |
Competitor B |
Europe |
Why Is This Important for R&D and Investment?
- The broad chemical and method claims position this patent as a key property right within this drug class.
- Licensing opportunities and collaborations are likely, given the targeted indications.
- Patent expiry around 2040 allows for extended commercial development and market exclusivity.
Key Takeaways
- U.S. Patent 11,975,096 protects a broad class of heterocyclic compounds with specific therapeutic applications.
- Claim scope includes both compounds and methods of treatment, with considerable breadth in chemical structure.
- The patent landscape shows active competition, particularly from firms developing similar compounds, emphasizing the importance of clearance and freedom-to-operate due diligence.
- Market potential depends on the continued patent portfolio strength and clinical development progress.
FAQs
1. Does the patent cover all possible substituents for the chemical core?
No. The claims specify certain substituents, but the broad language allows for various modifications within the defined structural framework.
2. Which therapeutic areas are targeted by this patent?
Primarily diseases linked to the biological target modulated by the compounds, including cancer, neurodegenerative, and inflammatory diseases.
3. Is there prior art that limits the scope of this patent?
Yes. Similar structures and uses previously existed, but the patent claims specify novel modifications and methods that distinguish it from prior art.
4. How does this patent compare with competitors’ patents?
It offers broader chemical claim coverage but faces overlap with patents from companies working on similar heterocyclic compounds.
5. When does this patent expire?
Assuming standard extensions, it is set to expire around 2040, subject to maintenance fees and potential patent term adjustments.
References
- U.S. Patent and Trademark Office. (2023). Patent No. 11,975,096. Retrieved from https://patents.google.com/patent/US11975096
- Patent landscape reports and filings from the USPTO and international patent databases.
- Industry reports on heterocyclic pharmaceutical patent trends, 2018–2022.
More… ↓
⤷ Start Trial
|
